Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenK01Clinical trial: Optional / allowed

Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)

National Institutes of Health (NIH) · NIH Institute/Center · PAR-25-091

Source: Grants.gov · View original posting ↗

Award
Up to $75K
Deadline
Jan 7, 2028
Letter of intent
Mechanism
K01
Duration
Expected awards
Funding cycle
Standard NIH dates
Open date
Jan 10, 2025
Total funding
Clinical trial
Optional / allowed
Early careerSmall businessHigher educationGovernmentNonprofitForeign entities

Funding context

35%of applications funded

Based on FY2024 NIH (all institutes) K01 applications (220 of 629 applications awarded).

Institute-specific data wasn’t available — showing the NIH-wide rate for this mechanism.

Payline: NIH discontinued percentile paylines for 2026 under its Unified Funding Strategy ↗ — scores are now weighed in context rather than against a fixed cutoff.

NIH-wide K01, all institutes.

Aggregate historical data by institute, mechanism, and fiscal year — context for planning, not a prediction for this opportunity. Source ↗

Research areas

Basic mechanisms & biology

Auto-classified from the title and description (keyword-based) — may be imperfect.

Description

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces a program that provides NIDDK-supported K01, K08, K23, and K25 recipients the opportunity to apply for Small Grant (R03) support at some point during the latter years of their award period of their K award. Through the use of this mechanism, the NIDDK is seeking to enhance the capability of its K01, K08, K23, and K25 award recipients to conduct research as they complete their transition to fully independent investigator status. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that may provide preliminary data to support a subsequent R01, or equivalent, application.

Data notes: administering NIH institute could not be identified from the opportunity number.